이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Unicompartmental Versus Total Knee Replacement for Medial Compartment Knee Osteoarthritis (FLEX-UNI)

2026년 9월 21일 업데이트: Golden Jubilee National Hospital

A Functional, Clinical, and Biomechanical Examination of Unicompartmental Versus Total Knee Arthroplasty for Medial Compartment Knee Osteoarthritis (FLEX-UNI): A Randomized Controlled Trial

For patients with osteoarthritis affecting only the inner part of the knee, surgeons can offer either a partial knee replacement, which resurfaces the worn compartment alone, or a total knee replacement. Both are recommended treatments, but there is no agreement on when to choose one over the other. Partial knee replacement preserves the anterior cruciate ligament and more of the natural knee, and recovery is usually quicker, but it is used in only about one in ten knee replacements in the United Kingdom.

Studies comparing the two have mostly relied on patient questionnaires, which may not be sensitive enough to detect differences in how the knee actually functions. Studies that have measured movement directly have concentrated on level walking, which is not demanding enough to separate the two operations. Difficulty with stairs is one of the longest lasting problems patients report after knee replacement.

The FLEX-UNI trial will compare the two operations using three-dimensional motion analysis during more demanding everyday activities. Forty patients who are suitable for a partial knee replacement will be randomly allocated to receive either a partial or a total knee replacement. Patients and the researchers measuring their movement will not know which operation was performed. The main measurement is how far the operated knee bends while stepping down from a 20 cm step, measured one year after surgery. Movement during walking, stair climbing, slopes, sitting and standing, and balance will also be measured, along with questionnaires, x-rays, and complications. Results will be compared against measurements from people with healthy knees.

연구 개요

상태

모집하지 않고 적극적으로

정황

개입 / 치료

상세 설명

FLEX-UNI is a single-centre, prospective, randomized, double-blinded, controlled superiority trial comparing medial unicompartmental knee arthroplasty (UKA) with total knee arthroplasty (TKA) in patients with anteromedial knee osteoarthritis. Forty participants will be randomized 1:1. The trial is conducted at a high-volume elective arthroplasty centre and participants are followed for 12 months.

Participants are identified from the clinic lists of participating consultant orthopaedic surgeons and screened against the eligibility criteria by a member of the research team and by the treating consultant. Following written consent and baseline assessment, participants are randomized using sequentially numbered, opaque, sealed envelopes prepared and opened by a member of the research team not involved in screening, recruitment, or outcome assessment.

Participants allocated to UKA receive a cemented medial fixed-bearing Persona Partial Knee (Zimmer Biomet, Warsaw, Indiana, USA), implanted using a spacer block technique that resurfaces the medial compartment without deliberate correction of limb alignment. Participants allocated to TKA receive a cemented Triathlon cruciate-retaining total knee system without patellar resurfacing (Stryker, Mahwah, New Jersey, USA), implanted using a measured resection technique with a mechanical alignment target. Both procedures use conventional manual instrumentation, without robotic assistance or computer navigation, and are performed by the same group of consultant surgeons, each of whom performs both operations.

Suitability for medial UKA is confirmed intraoperatively at arthrotomy in all participants, including those allocated to TKA. Participants allocated to UKA who are found at arthrotomy to be unsuitable, principally because of disease progression beyond anteromedial osteoarthritis or a deficient anterior cruciate ligament, undergo TKA.

Participants are blinded to allocation. A standard-size sterile dressing is applied to the surgical wound by an independent healthcare support worker before biomechanical testing to conceal scar length, and participants are not shown their postoperative radiographs unless there is a clinical need. Research staff performing biomechanical assessment, outcome scoring, and statistical analysis are blinded to allocation, with unblinding only after analysis is complete. The treating surgeon cannot be blinded.

Assessments take place preoperatively, immediately postoperatively, and at six weeks, six months, and 12 months. Biomechanical assessment is performed in the centre's Motion Analysis Laboratory using a Vicon motion capture system (Vicon Motion Systems Ltd, Yarnton, UK) and two AMTI force plates (Advanced Mechanical Technology Inc., Watertown, Massachusetts, USA). Tasks are level walking, incline walking, decline walking, step ascent, step descent, sit-to-stand-to-sit, and single-leg balance.

A matched healthy control group is drawn from an existing motion analysis database held at the study centre, comprising individuals without known knee pathology previously assessed using an identical protocol under separate ethical approval. Control data do not contribute to the primary comparison between arms and are used only to contextualize findings against values expected in a healthy population. Healthy controls are not prospectively enrolled in this trial.

The sample size was calculated for the primary outcome, assuming 95 degrees for the UKA group and 89 degrees for the TKA group with a pooled standard deviation of 5.5 degrees, two-sided alpha of 0.05, and 80% power, giving 15 participants per group for an analysis of covariance with baseline as a covariate. Allowing for an estimated 10% intraoperative conversion from UKA to TKA and 15% loss to follow-up, the recruitment target is 20 per group. The trial is powered for the primary outcome alone, and all secondary outcomes are exploratory.

The primary analysis is performed on the per-protocol population, defined as participants who received their randomized implant and completed the 12-month biomechanical assessment. Participants found intraoperatively unsuitable for UKA at arthrotomy are excluded from the primary analysis regardless of allocation.

The trial is funded by Zimmer GmbH (Winterthur, Switzerland).

연구 유형

중재적

등록 (추정된)

40

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • West Dunbartonshire
      • Clydebank, West Dunbartonshire, 영국, G81 4DY
        • Golden Jubilee National Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Suitable for medial unicompartmental knee arthroplasty
  • Aged between 18 and 75 years inclusive
  • Taller than 1.5m in height (the 10th percentile for the population)
  • Functionally intact anterior cruciate ligament
  • Able to give informed consent
  • Able to return to the study centre for follow-up
  • BMI under 40

Exclusion Criteria:

  • Inflammatory joint disease e.g. rheumatoid arthritis
  • Previous hip procedure within the previous twelve months
  • Previous knee surgery other than arthroscopy and medial menisectomy
  • Previous ankle surgery
  • Symptomatic foot, hip or spinal pathology
  • Any medical condition limiting normal ambulation e.g. stroke, Charcot-Marie-Tooth disease, severe lymphedema, advanced cardiac disease
  • Unable to read and understand English and follow verbal and visual instructions unless they can bring a relative or friend to all study assessments to act as a translator

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 더블

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Unicompartmental knee arthroplasty (UKA)

Description: Cemented medial fixed-bearing unicompartmental knee arthroplasty, implanted using a spacer block technique that resurfaces the medial compartment without deliberate correction of limb alignment, using conventional manual instrumentation

Cemented medial fixed-bearing unicompartmental knee arthroplasty using the Persona Partial Knee (PPK; Zimmer Biomet, Warsaw, Indiana, USA).

활성 비교기: Total knee arthroplasty (TKA)

Cemented cruciate-retaining total knee arthroplasty without patellar resurfacing, implanted using a measured resection technique with a mechanical alignment target, using conventional manual instrumentation. This is the standard total knee implant used at the study centre.

Cemented Triathlon cruciate-retaining total knee system without patellar resurfacing (Stryker, Mahwah, New Jersey, USA).

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Maximum knee flexion of the operated knee during step descent
기간: 12 months post-operatively

Peak flexion angle of the operated knee in the sagittal plane, in degrees, during descent from a 20 cm step with the operated limb acting as the trailing limb, measured using three-dimensional motion analysis.

12 months post-operatively

2차 결과 측정

결과 측정
측정값 설명
기간
Maximum knee flexion during step descent, operated limb as trailing limb
기간: 6 months post-operatively
6 months post-operatively
Knee kinematics and kinetics
기간: baseline, 6 months, 12 months

Knee kinematics: sagittal, coronal, and transverse plane joint angles during level walking, incline walking, decline walking, step ascent, step descent, and sit-to-stand-to-sit.

Knee kinetics: knee joint moments and ground reaction forces during tasks performed on force plates.

baseline, 6 months, 12 months
Spatiotemporal and balance
기간: baseline, 6 months, 12 months.

Spatiotemporal gait parameters: walking speed and step length. Single-leg balance: time to failure, in seconds.

baseline, 6 months, 12 months.
Patient satisfaction
기간: 6 weeks, 6 months, 12 months

Patient satisfaction on a Fpur-point Likert scale.

6 weeks, 6 months, 12 months
Radiographic assessment
기간: to 12 months postoperatively

11. Radiographic assessment of implant position, alignment, and signs of loosening or migration, using a modified Knee Society Roentgenographic Evaluation and Scoring System. No summary score is produced.

to 12 months postoperatively
Complications and adverse events
기간: to 12 months postoperatively

12. Complications and adverse events, including deep and superficial infection, thromboembolic events, intraoperative fracture, neurovascular injury, wound complications, and any reoperation or revision.

to 12 months postoperatively
Implant survivorship
기간: 12 months

Implant survivorship, reported as the number of implants in situ.

12 months
Intraoperative conversion from unicompartmental to total knee arthroplasty, reported as the number of participants.
기간: day of surgery
day of surgery

기타 결과 측정

결과 측정
측정값 설명
기간
Patient reported outcome (Oxford Knee Score)
기간: baseline, 6 weeks, 6 months, 12 months.

Oxford Knee Score, 12 items, total score 0 to 48, higher scores indicate better outcome.

baseline, 6 weeks, 6 months, 12 months.
Patient reported outcome (EuroQual 5D-5L questionnaire)
기간: baseline, 6 weeks, 6 months, 12 months.

9. EQ-5D-5L index value and visual analogue scale.

baseline, 6 weeks, 6 months, 12 months.
Patient reported outcome (Forgotten Joint Score)
기간: 6 weeks, 6 months, 12 months.

Forgotten Joint Score-12, score 0 to 100, higher scores indicate greater ability to forget the operated joint.

6 weeks, 6 months, 12 months.
Patient reported outcome (University of California Los Angelees Activity Score)
기간: baseline, 6 weeks, 6 months, 12 months.

8. UCLA Activity Score, single item, 1 to 10, higher scores indicate greater activity.

baseline, 6 weeks, 6 months, 12 months.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Nicholas Ohly, FRCS Ed, Golden Jubilee University National Hospital

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2021년 4월 26일

기본 완료 (추정된)

2027년 10월 15일

연구 완료 (추정된)

2027년 10월 15일

연구 등록 날짜

최초 제출

2019년 7월 17일

QC 기준을 충족하는 최초 제출

2021년 6월 3일

처음 게시됨 (실제)

2021년 6월 4일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 24일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 21일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • Ortho 18-03
  • 251071 (기타 식별자: Health Research Authority)
  • 19/SS/0124 (기타 식별자: Scotland B Research Ethics Committee)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .